颈动脉内膜剥脱术与颈动脉支架置入术后再狭窄的预测因素:单中心回顾性队列研究
结果显示严重再狭窄发生率为5.5%,CEA与CAS相似;任何再狭窄发生率为10.3%。女性与严重再狭窄风险升高相关,就诊时同侧症状严重程度较高与再狭窄风险降低相关,CAS相比CEA任何再狭窄风险更低;CEA后再狭窄与糖尿病相关,CAS后再狭窄与吸烟相关。
要点
- CEA与CAS后严重再狭窄率约5%,两者相似。
- 女性严重再狭窄风险更高(HR 1.77)。
- 就诊时同侧症状越重,再狭窄风险越低。
核心结论
- CEA和CAS后严重再狭窄均约占5%,预测因素因手术方式而异。
- 糖尿病与CEA后再狭窄相关,吸烟与CAS后再狭窄相关。
- 就诊时同侧症状负担较高与再狭窄风险降低 consistently 相关。
研究设计与样本
- 主要结局为严重再狭窄(≥70%再狭窄和/或再狭窄>30天后再次干预),次要结局为任何再狭窄(≥50%)。
- 采用多变量Cox比例风险模型识别独立预测因素,并分别对CEA和CAS进行分析。
主要发现
- 严重再狭窄发生于5.5%的患者,CEA与CAS发生率相似;任何再狭窄发生于10.3%(CEA 10.7% vs. CAS 9.0%)。
- 总体队列中,女性发生严重再狭窄的风险更高(HR 1.77,95%CI 1.03-3.02)。
- 就诊时同侧症状严重程度较高与严重再狭窄(HR 0.73,95%CI 0.55-0.95)和任何再狭窄(HR 0.67,95%CI 0.55-0.82)风险降低相关。
- CAS相比CEA任何再狭窄风险更低(HR 0.41,95%CI 0.24-0.68)。
- 在手术特异性分析中,糖尿病与CEA后任何再狭窄显著相关,吸烟与CAS后两个阈值的再狭窄均相关。
关键数值与推荐
- 严重再狭窄定义:≥70%再狭窄和/或再狭窄>30天后再次干预。
- 任何再狭窄定义:≥50%再狭窄。
临床怎么用
- CEA术后应关注糖尿病患者的再狭窄风险,CAS术后应关注吸烟者的再狭窄风险。
- 女性患者可能需更密切的再狭窄监测。
- 就诊时同侧症状严重程度较高的患者再狭窄风险较低,可据此调整随访策略。
局限性
- 单中心回顾性设计可能限制结果的普遍性。
- 平均随访2.9年,可能不足以捕捉晚期再狭窄事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Restenosis after carotid revascularisation remains a clinical concern, yet predictors of restenosis after carotid endarterectomy (CEA) and carotid artery stenting (CAS) are still incompletely defined. This study aimed to identify clinical and procedural predictors of restenosis after CEA and CAS. METHODS: This was a single centre retrospective cohort study. All patients who underwent primary CEA or CAS between January 2011 and December 2024 were included. The primary outcome was severe restenosis, (≥ 70% restenosis and/or re-intervention for restenosis > 30 days). The secondary outcome was any restenosis (≥ 50%). Multivariable Cox proportional hazards models were constructed to identify independent predictors, including separate analyses for CEA and CAS. RESULTS: Included were 1 011 patients (744 CEA; 267 CAS), with mean follow up of 2.9 years. Severe restenosis occurred in 5.5% of patients, with similar rates after CEA and CAS. Any restenosis occurred in 10.3% (10.7% CEA vs. 9.0% CAS). In the overall cohort, women had a higher hazard of developing severe restenosis (hazard ratio [HR] 1.77, 95% confidence interval [CI] 1.03 - 3.02), whereas greater ipsilateral symptom severity at presentation was associated with a lower hazard of both severe (HR 0.73, 95% CI 0.55 - 0.95) and any restenosis (HR 0.67, 95% CI 0.55 - 0.82). CAS was associated with a lower hazard of any restenosis compared with CEA (HR 0.41, 95% CI 0.24 - 0.68). In procedure specific analyses, diabetes mellitus was significantly associated with any restenosis after CEA, while smoking was associated with restenosis after CAS at both thresholds. CONCLUSION: Severe restenosis occurs in approximately 5% of patients following both CEA and CAS. Predictors differed by procedure: diabetes mellitus was associated with restenosis after CEA, whereas smoking after CAS. Higher ipsilateral symptom burden at presentation was consistently associated with a lower risk of restenosis. These findings provide insight into procedure specific risk profiles and may inform future risk stratified follow up studies.
引用
- Geeraedts AJH, Kraai TW, Gareb B, et al. Predictors of Restenosis After Carotid Endarterectomy and Carotid Artery Stenting: A Single Centre Retrospective Cohort Study. Eur J Vasc Endovasc Surg. 2026. PMID: 42778135. doi:10.1016/j.ejvs.2026.09.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。